$322 Million is the total value of AIGH Capital Management LLC's 98 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 48.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $67,617,000 | -51.3% | 410,000 | -50.0% | 21.01% | -42.5% |
| New | ADTRAN HOLDINGS INC | $22,733,000 | – | 1,161,019 | +100.0% | 7.06% | – | |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $22,544,000 | +16.6% | 2,739,255 | -7.1% | 7.01% | +37.7% |
| MTRN | Buy | MATERION CORP | $19,295,000 | +44.4% | 241,189 | +33.1% | 6.00% | +70.6% |
| TGAN | Sell | TRANSPHORM INC | $18,978,000 | +34.9% | 3,772,875 | -0.2% | 5.90% | +59.4% |
| DZSI | Sell | DZS INC | $18,960,000 | -31.0% | 1,677,879 | -0.6% | 5.89% | -18.5% |
| AVNW | Buy | AVIAT NETWORKS INC | $14,674,000 | +43.7% | 535,918 | +31.4% | 4.56% | +69.6% |
| TELA | Buy | TELA BIO INC | $13,033,000 | +504.5% | 1,529,669 | +399.1% | 4.05% | +614.3% |
| INDI | New | INDIE SEMICONDUCTOR INC | $10,634,000 | – | 1,452,766 | +100.0% | 3.30% | – |
| ANIP | Buy | ANI PHARMACEUTICALS INC | $10,105,000 | +39.3% | 314,406 | +28.6% | 3.14% | +64.5% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $9,990,000 | +52.8% | 3,887,172 | +14.8% | 3.10% | +80.5% |
| CAMP | CALAMP CORP | $8,974,000 | -7.9% | 2,336,942 | 0.0% | 2.79% | +8.8% | |
| SONO GROUP N V | $8,931,000 | -13.6% | 3,516,129 | 0.0% | 2.78% | +2.1% | ||
| SIMO | SILICON MOTION TECHNOLOGY COsponsored adr | $7,458,000 | -22.1% | 114,400 | 0.0% | 2.32% | -8.0% | |
| THTX | THERATECHNOLOGIES INC | $6,909,000 | -1.4% | 2,913,067 | 0.0% | 2.15% | +16.4% | |
| AIRG | AIRGAIN INC | $5,245,000 | -11.2% | 727,484 | 0.0% | 1.63% | +4.9% | |
| MRAM | Sell | EVERSPIN TECHNOLOGIES INC | $4,947,000 | -26.5% | 854,430 | -33.5% | 1.54% | -13.2% |
| SCPH | Sell | SCPHARMACEUTICALS INC | $4,936,000 | -24.0% | 757,063 | -43.8% | 1.53% | -10.2% |
| SCYX | Sell | SCYNEXIS INC | $4,696,000 | +12.8% | 1,957,054 | -12.6% | 1.46% | +33.2% |
| ICAD | Buy | ICAD INC | $3,686,000 | -32.3% | 1,755,634 | +29.0% | 1.15% | -20.0% |
| BKTI | BK TECHNOLOGIES CORPORATION | $3,310,000 | -9.1% | 1,373,750 | 0.0% | 1.03% | +7.4% | |
| MDNA | Buy | MEDICENNA THERAPEUTICS CORP | $3,193,000 | +20.6% | 3,850,154 | +69.4% | 0.99% | +42.5% |
| RFIL | RF INDS LTD | $2,944,000 | -7.3% | 512,037 | 0.0% | 0.92% | +9.6% | |
| APEN | New | APOLLO ENDOSURGERY INC | $2,802,000 | – | 508,536 | +100.0% | 0.87% | – |
| IDEAL PWR INC | $2,208,000 | -15.4% | 213,368 | 0.0% | 0.69% | -0.1% | ||
| LPTH | LIGHTPATH TECHNOLOGIES INC | $2,183,000 | -13.0% | 2,039,832 | 0.0% | 0.68% | +2.7% | |
| ARDX | Sell | ARDELYX INC | $1,770,000 | -20.5% | 1,487,476 | -60.6% | 0.55% | -6.1% |
| XFOR | X4 PHARMACEUTICALS INC | $1,706,000 | +77.3% | 997,719 | 0.0% | 0.53% | +109.5% | |
| EOLS | Buy | EVOLUS INC | $1,610,000 | -19.6% | 200,000 | +15.9% | 0.50% | -5.1% |
| New | CAPSTONE GREEN ENERGY CORP | $1,593,000 | – | 900,000 | +100.0% | 0.50% | – | |
| OSMT | Buy | RVL PHARMACEUTICALS PLC | $1,553,000 | +1238.8% | 739,531 | +770.1% | 0.48% | +1458.1% |
| Sell | COGNITION THERAPEUTICS INC | $1,516,000 | -36.4% | 798,335 | -12.3% | 0.47% | -24.9% | |
| Buy | CONTEXT THERAPEUTICS INC | $1,434,000 | +20.7% | 1,291,771 | +8.4% | 0.45% | +42.5% | |
| RNAZ | TRANSCODE THERAPEUTICS INC | $1,418,000 | -12.7% | 1,289,000 | 0.0% | 0.44% | +3.3% | |
| FKWL | FRANKLIN WIRELESS CORP | $1,139,000 | -8.4% | 390,000 | 0.0% | 0.35% | +8.3% | |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $1,140,000 | – | 1,200,000 | +100.0% | 0.35% | – |
| VCNX | VACCINEX INC | $1,030,000 | -54.2% | 2,081,801 | 0.0% | 0.32% | -45.9% | |
| MYO | MYOMO INC | $999,000 | -3.7% | 617,179 | 0.0% | 0.31% | +13.6% | |
| New | SOLENO THERAPEUTICS INC | $708,000 | – | 424,089 | +100.0% | 0.22% | – | |
| PCSA | PROCESSA PHARMACEUTICALS INC | $686,000 | -19.6% | 303,703 | 0.0% | 0.21% | -4.9% | |
| New | CELLECTAR BIOSCIENCES INC | $586,000 | – | 174,422 | +100.0% | 0.18% | – | |
| New | ABEONA THERAPEUTICS INC | $428,000 | – | 140,644 | +100.0% | 0.13% | – | |
| NBSE | Sell | NEUBASE THERAPEUTICS INC | $345,000 | -68.0% | 872,023 | -15.1% | 0.11% | -62.3% |
| CMBM | New | CAMBIUM NETWORKS CORP | $325,000 | – | 19,182 | +100.0% | 0.10% | – |
| ATNX | New | ATHENEX INC | $269,000 | – | 1,000,134 | +100.0% | 0.08% | – |
| NLSPW | New | NLS PHARMACEUTICS LTD*w exp 09/25/202 | $158,000 | – | 633,361 | +100.0% | 0.05% | – |
| New | SAVERONE 2014 LTD*w exp 06/02/202 | $128,000 | – | 428,330 | +100.0% | 0.04% | – | |
| CYTHW | New | CYCLO THERAPEUTICS INC*w exp 11/14/202 | $77,000 | – | 219,795 | +100.0% | 0.02% | – |
| NLSPW | Sell | NLS PHARMACEUTICS LTDcall | $49,000 | -50.5% | 194,060 | -76.5% | 0.02% | -42.3% |
| New | SAVERONE 2014 LTDcall | $42,000 | – | 141,364 | +100.0% | 0.01% | – | |
| RZLT | Sell | REZOLUTE INC | $33,000 | -88.0% | 11,866 | -86.0% | 0.01% | -86.1% |
| CYTHW | Sell | CYCLO THERAPEUTICS INCcall | $26,000 | -31.6% | 73,736 | -75.0% | 0.01% | -20.0% |
| New | PARABELLUM ACQUISITION CORP*w exp 99/99/999 | $8,000 | – | 450,214 | +100.0% | 0.00% | – | |
| Sell | PARABELLUM ACQUISITION CORPcall | $3,000 | -92.1% | 139,072 | -76.4% | 0.00% | -90.0% | |
| Exit | SAVERONE 2014 LTDcall | $0 | – | -570,194 | -100.0% | -0.05% | – | |
| BLIN | Exit | BRIDGELINE DIGITAL INC | $0 | – | -178,003 | -100.0% | -0.06% | – |
| BW | Exit | BABCOCK & WILCOX ENTERPRISES | $0 | – | -163,199 | -100.0% | -0.26% | – |
| Exit | SAVERONE 2014 LTDsponsored ads | $0 | – | -449,100 | -100.0% | -0.27% | – | |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -6,361,349 | -100.0% | -0.31% | – |
| CLRB | Exit | CELLECTAR BIOSCIENCES INC | $0 | – | -1,837,046 | -100.0% | -0.43% | – |
| CYBE | Exit | CYBEROPTICS CORP | $0 | – | -509,917 | -100.0% | -4.69% | – |
| ADTN | Exit | ADTRAN INC | $0 | – | -1,161,019 | -100.0% | -5.36% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SCPHARMACEUTICALS INC | 15 | Q2 2024 | 8.5% |
| IDEAL PWR INC | 14 | Q2 2024 | 2.5% |
| FRANKLIN WIRELESS CORP | 14 | Q2 2024 | 2.9% |
| LIGHTPATH TECHNOLOGIES INC | 13 | Q2 2024 | 3.0% |
| MYOMO INC | 13 | Q2 2024 | 5.3% |
| AVIAT NETWORKS INC | 12 | Q3 2023 | 6.8% |
| THERATECHNOLOGIES INC | 11 | Q2 2023 | 2.9% |
| MEDICENNA THERAPEUTICS CORP | 11 | Q3 2023 | 1.1% |
| PARATEK PHARMACEUTICALS INC | 10 | Q1 2023 | 3.2% |
| COGNITION THERAPEUTICS INC | 10 | Q2 2024 | 1.5% |
View AIGH Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Bridgeline Digital, Inc. | May 21, 2021 | 627,419 | 9.7% |
View AIGH Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-06 |
| 13F-HR | 2024-08-07 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
View AIGH Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.